Dalgleish Scott 4
4 · Oncology Institute, Inc. · Filed Mar 23, 2022
Insider Transaction Report
Form 4
Dalgleish Scott
Chief Financial Officer
Transactions
- Award
Common stock
2022-03-21+32,092→ 151,008 total - Award
Stock Option (right to buy)
2022-03-21+26,062→ 26,062 totalExercise: $7.09Exp: 2032-03-21→ Common stock (26,062 underlying)
Footnotes (2)
- [F1]Represents RSUs with 1/3rd of the RSUs vesting on the second anniversary of November 12, 2021 ("the Vesting Commencement Date"), with the remaining RSUs vesting in four equal annual installments beginning on the third anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the sixth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
- [F2]The stock options vest as to 1/3rd of the options granted on the second anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the third anniversary of the Vesting Commencement Date, with all options becoming vested on the sixth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.